Hikma's Generic Methylprednisolone Sodium Succinate Receives Approval in the U.S.
Pharma major Dr Reddy's Laboratories Ltd on Tuesday said it has launched its generic Methylprednisolone Sodium Succinate for injection, indicated for various conditions including arthritis, blood disorders and severe allergic reactions, in the US market. The injection is the generic equivalent of SOLU-MEDROL and has been approved by the US Food and Drug Administration (USFDA), the company said in a regulatory filing.
Enforcement Report - Week of January 29, 2020
Enforcement Report - Week of March 21, 2018
Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Methylprednisolone Sodium Succinate for Injection, USP
SCHAUMBURG, Ill., March 5, 2018 /PRNewswire/ -- Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of ten lots of Methylprednisolone Sodium Succinate for Injection, USP, 40mg, 125mg, and 1g. A detailed listing of products and lots is listed below. These products were manufactured by Gland Pharma Ltd. and distributed by Sagent Pharmaceuticals.
Amneal Generic Methylprednisolone Sodium Succinate Receives Approval In US
Hikma Farmaceutica`s Generic Methylprednisolone Sodium Succinate approved in US as corticosteroid